BackSino Biopharmaceutical Overview

Sino Biopharmaceutical Operating Income

Operating Income for SBHMY.

Quarterly Operating Income

$1.88B
↑ 275.49% YoY

As of Jun 30, 2025

Annual Operating Income (TTM)

$6.44B
↑ 388.79% YoY

Trailing 12 months ending Jun 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin